Trademarks

INREBIC

Serial number
88207119
Registration number
5962898
Filed
2018-11-27
Registered
2020-01-14
Status
Registered (USPTO status code 702, 2025-09-12; as of the dataset)
Classes
005
Elsewhere
USPTO TSDR record (current status) ↗
Source
TRTYRAP, file of 2026-04-03

Goods and services

Pharmaceutical preparations for use in the treatment of myeloproliferative diseases, myelofibrosis, autoinflammatory disease, autoimmune disease, blood disease, cancer in the fields of oncology, immunology and inflammation; pharmaceutical preparations, namely, cytokine inhibitory drugs; pharmaceutical preparations that modulate the immune system

Owners

OwnerRoleEntityPlaceAlso on furp.orgSource
Celgene CorporationOriginal applicantCorporationSummit, NJTRTYRAP, file of 2026-04-03
IMPACT BIOMEDICINES, INC.New applicant before publication, Owner at publicationCorporationSUMMIT, NJIMPACT BIOMEDICINES, INC. State business registration EXACT high confidence: identical full name and stateTRTYRAP, file of 2026-04-03
IMPACT BIOMEDICINES, INC.Original registrantCorporationSummit, NJIMPACT BIOMEDICINES, INC. State business registration EXACT high confidence: identical full name and stateTRTYRAP, file of 2026-04-03

Assignment history

RecordedWhatFromToReel/frameSource
2018-12-27Assignment
Assigns the entire interest
CELGENE CORPORATIONIMPACT BIOMEDICINES, INC. SUMMIT, NJ6509/784TRASECO, file of 2026-09-29

USPTO bulk data: the Trademark Case Files Dataset (TRCFECO2; the latest release, March 2024, runs through 2023) for marks, owners, classes and goods and services; the Trademark Assignment Dataset (TRASECO) for assignments. Marks filed in the last 20 years, plus older marks still registered. Status here is read from the dataset’s dates and status code; TSDR has the current status. Links to other records are by name (and state): EXACT means the identical full name and state; FUZZY means a looser name match, with the confidence shown.